Reevaluation of the locoregional recurrence rate in melanoma patients with a positive sentinel node compared to patients with palpable nodal involvement

Annals of Surgical Oncology

Volumn 17, Issue 2, 2010, Pages 521-526

  Veenstra, Hidde J ^a   Van Der Ploeg, Iris M C ^b   Wouters, Michel W J M ^a   Kroon, Bin B R ^a   Nieweg, Omgo E ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HUMAN; IN-TRANSIT METASTASIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; PALPATION; REGIONAL METASTASIS; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77149171751     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0776-y     Document Type: Article

References (25)

1. DL Morton JF Thompson AJ Cochran, et al. 2006 Sentinel-node biopsy or nodal observation in melanoma N Engl J Med 355 1307 1317 10.1056/NEJMoa060992 1:CAS:528:DC%2BD2sXisVaqtr4%3D 17005948 (Pubitemid 44465459)
2. SH Estourgie OE Nieweg BBR Kroon 2004 High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma Br J Surg 91 1370 1371 10.1002/bjs.4692 1:STN:280:DC%2BD2cvpsFeitQ%3D%3D 15376178 (Pubitemid 39331464)
3. SH Estourgie OE Nieweg RA Valdés Olmos CA Hoefnagel BBR Kroon 2003 Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years Ann Surg Oncol 10 681 688 10.1245/ASO.2003.01.023 12839854 (Pubitemid 40486901)
4. MG Statius Muller PA van Leeuwen PJ van Diest, et al. 2002 Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients World J Surg 26 1405 1411 10.1007/s00268-002-6197-8 12297910 (Pubitemid 36920195)
5. D Van Poll JF Thompson MH Colman, et al. 2005 A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma Ann Surg Oncol 12 597 608 10.1245/ASO.2005.08.012 16021534 (Pubitemid 41126089)
6. TM Pawlik MI Ross MM Johnson, et al. 2005 Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy Ann Surg Oncol 12 587 596 10.1245/ASO.2005.05.025 16021533 (Pubitemid 41126088)
7. MH Doting HJ Hoekstra JT Plukker, et al. 2002 Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma Eur J Surg Oncol 28 673 678 10.1053/ejso.2002.1297 1:STN:280: DC%2BD38vpslyksw%3D%3D 12359207
8. JM Thomas MA Clark 2004 Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma Eur J Surg Oncol 30 686 691 10.1016/j.ejso.2004.04.004 1:STN:280:DC%2BD2czltleltA%3D%3D 15256245 (Pubitemid 39060740)
9. IM Van der Ploeg RA Valdés Olmos OE Nieweg, et al. 2007 The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma J Nucl Med 48 1756 1760 10.2967/jnumed.107.043372 17942802 (Pubitemid 350099318)
10. OE Nieweg PJ Tanis BBR Kroon 2001 The definition of a sentinel node Ann Surg Oncol 8 538 541 10.1007/s10434-001-0538-y 1:STN:280: DC%2BD38%2Fit1ertQ%3D%3D 11456054
11. JM Klaase BBR Kroon AN van Geel, et al. 1994 Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan Surgery 115 39 45 1:STN:280:DyaK2c7ht1Kmtw%3D%3D 8284759
12. TM Pawlik MI Ross JF Thompson AM Eggermont JE Gershenwald 2005 The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes J Clin Oncol 23 4588 4590 10.1200/JCO.2005.12. 245 16034040 (Pubitemid 46224060)
13. L Kretschmer I Beckmann KM Thoms, et al. 2006 Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma Ann Surg Oncol 13 1105 1112 10.1245/ASO.2006.07.020 16865591 (Pubitemid 44337970)
14. IM Van der Ploeg BB Kroon N Antonini RA Valdes Olmos OE Nieweg 2009 Is completion lymph node dissection needed in case of minimal melanoma metastasis in the sentinel node? Ann Surg 249 1003 1007 10.1097/SLA.0b013e3181a77eba 19474678
15. H Starz K Siedlecki BR Balda 2004 Sentinel lymphonodectomy and s-classification: a successful strategy for better prediction and improvement of outcome of melanoma Ann Surg Oncol 11 162S 168S 15023745
16. OE Nieweg SH Estourgie 2004 What is a sentinel node and what is a false-negative sentinel node? Ann Surg Oncol 11 169S 173S 15023746
17. A Calabro SE Singletary CM Balch 1989 Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases Arch Surg 124 1051 1055 1:STN:280:DyaL1MzntlGrtw%3D%3D 2774907
18. L Borgognoni C Urso L Vaggelli, et al. 2004 Sentinel node biopsy procedures with an analysis of recurrence patterns and prognosis in melanoma patients: technical advantages using computer-assisted gamma probe with adjustable collimation Melanoma Res 14 311 319 10.1097/01.cmr.0000133968.28172. 6e 15305163 (Pubitemid 39159145)
19. RJ Vuylsteke PA van Leeuwen MG Statius Muller, et al. 2003 Clinical outcome of stage I/II melanoma patients after selective sentinel lymph node dissection: long-term follow-up results J Clin Oncol 21 1057 1065 10.1200/JCO.2003.07.170 1:STN:280:DC%2BD3s7itlaktQ%3D%3D 12637471 (Pubitemid 46594135)
20. Gershenwald JE, Schacherer C, Emerson M, et al. Patterns of failure and survival analysis in sentinel lymph node positive melanoma patients. Proc Am Soc Clin Oncol. 2001. Abstract.
21. BM Clary B Mann MS Brady JJ Lewis DG Coit 2001 Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection Ann Surg Oncol 8 328 337 10.1007/s10434-001-0328-6 1:STN:280:DC%2BD3M3lsVWnsw%3D%3D 11352306
22. SE Singletary SL Tucker AW Boddie Jr 1988 Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma Cancer 61 1437 1440 10.1002/1097-0142(19880401)61:7<1437::AID-CNCR2820610726>3. 0.CO;2-Z 1:STN:280:DyaL1c7ltVOhsg%3D%3D 3345495
23. AC Buzaid MI Ross CM Balch, et al. 1997 Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system J Clin Oncol 15 1039 1051 1:STN:280: DyaK2s3htlymtw%3D%3D 9060544
24. CM Balch AC Buzaid SJ Soong, et al. 2001 Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 3635 3648 1:STN:280:DC%2BD3MvlvV2ktQ%3D%3D 11504745
25. L Kretschmer I Beckmann KM Thoms, et al. 2005 High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma (Br J Surg 2004;91:1370-1371) Br J Surg 92 253 254 10.1002/bjs.4945 1:STN:280:DC%2BD2M7itVKmtw%3D%3D 15685696 (Pubitemid 40269348)